Status:
COMPLETED
Molecular Markers of Acute Kidney Injury in Elderly Deceased Donors
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Conditions:
Kidney Transplantation
Acute Kidney Injury
Eligibility:
All Genders
Brief Summary
Scoring systems that combine donor clinical and morphological parameters to predict outcome of kidney transplantation lack enough specificity to be generally accepted. Compare to classical histology, ...
Detailed Description
The aim is to create a prediction model of early clinical outcome (delayed graft function) based on donor and recipient clinical variables, donor eGFR, urinary AKI biomarkers, histology (glomeruloscle...
Eligibility Criteria
Inclusion
- All DBD (donation after brain death) donors whose kidneys will be procured by transplant team of Institute for Clinical and Experimental Medicine (IKEM) in donor hospital.
- All DBD (donation after brain death) donors whose kidneys will be procured by transplant team of Institute for Clinical and Experimental Medicine (IKEM) at IKEM.
Exclusion
- Donors with circulatory death
- Donors with machine perfusion
- Donors with multiorgan transplantation.
Key Trial Info
Start Date :
June 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06171438
Start Date
June 11 2021
End Date
October 31 2023
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Clinical and Experimental Medicine
Prague, Czechia, 140 21